Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia

British Journal of Haematology

Volumn 162, Issue 3, 2013, Pages 304-312

  Salomon, Ophira ^a   Rosenberg, Nurit ^a  

^a The Amalia Biron Research Institute of Thrombosis and Hemostasis   (Israel)

Author keywords

Fetal blood sampling; Human platelet antibodies; Human platelet antigen; Intracranial haemorrhage; Neonatal alloimmune thrombocytopenia

Indexed keywords

ALLOANTIBODY; CORTICOSTEROID; EPITOPE; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; IMMUNOGLOBULIN; THROMBOCYTE ANTIGEN; THROMBOCYTE ANTIGEN 1A; THROMBOCYTE ANTIGEN 1A ANTIBODY; THROMBOCYTE ANTIGEN 1B; THROMBOCYTE ANTIGEN 22BW; THROMBOCYTE ANTIGEN 26BW; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; BRAIN HEMORRHAGE; CELLULAR IMMUNITY; CESAREAN SECTION; DISEASE SEVERITY; DNA MICROARRAY; DNA POLYMORPHISM; DOSE RESPONSE; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG SAFETY; FATIGUE; GENE FREQUENCY; GENOTYPE; HEMOLYTIC ANEMIA; HUMAN; IMMUNOASSAY; IMMUNOPATHOLOGY; IMMUNOPROPHYLAXIS; INTRAUTERINE BLOOD TRANSFUSION; MYALGIA; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA; NEWBORN CARE; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRENATAL CARE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVIEW; RISK ASSESSMENT; THROMBOCYTE TRANSFUSION;

FETAL BLOOD SAMPLING; HUMAN PLATELET ANTIBODIES; HUMAN PLATELET ANTIGEN; INTRACRANIAL HAEMORRHAGE; NEONATAL ALLOIMMUNE THROMBOCYTOPENIA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; INTEGRIN BETA3; ISOANTIBODIES; MICE; POSTNATAL CARE; PREGNANCY; PRENATAL CARE; RECEPTORS, FC; RISK ASSESSMENT; THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE;

EID: 84880279261     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12372     Document Type: Review

References (64)

1. Van Den Akker, E.S., Oepkes, D., Lopriore, E., Brand, A. & Kanhai, H.H. (2007) Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective. BJOG: An International Journal of Obstetrics and Gynaecology, 114, 469-473.
2. Allen, D., Verjee, S., Rees, S., Murphy, M.F. & Roberts, D.J. (2007) Platelet transfusion in neonatal alloimmune thrombocytopenia. Blood, 109, 388-389.
3. Altarescu, G., Eldar-Geva, T., Grisaru-Granovsky, S., Bonstein, L., Miskin, H., Varshver, I., Margalioth, E.J., Levy-Lahad, E. & Renbaum, P. (2012) Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies. Obstetrics and Gynecology, 119, 338-343.
4. Anani Sarab, G., Moss, M., Barker, R.N. & Urbaniak, S.J. (2009) Naturally processed peptides spanning the HPA-1a polymorphism are efficiently generated and displayed from platelet glycoprotein by HLA-DRB3*0101-positive antigen-presenting cells. Blood, 114, 1954-1957.
5. Bakchoul, T., Meyer, O., Agaylan, A., Bombard, S., Bein, G., Sachs, U.J., Salama, A. & Santoso, S. (2007) Rapid detection of HPA-1 alloantibodies by platelet antigens immobilized onto microbeads. Transfusion, 47, 1363-1368.
6. Bakchoul, T., Boylan, B., Sachs, U.J., Bein, G., Ruan, C., Santoso, S. & Newman, P.J. (2009) Blockade of maternal anti-HPA-1a mediated platelet clearance by an HPA-1a epitope-specific F(ab') in an in vivo mouse model of alloimmune thrombocytopenia. Transfusion, 49, 265-270.
7. Bakchoul, T., Kubiak, S., Krautwurst, A., Roderfeld, M., Siebert, H.C., Bein, G., Sachs, U.J. & Santoso, S. (2011) Low avidity anti-HPA-1a alloantibodies are capable of antigen-positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia. Transfusion, 51, 2455-2461.
8. Berkowitz, R.L., Kolb, E.A., McFarland, J.G., Wissert, M., Primani, A., Lesser, M. & Bussel, J.B. (2006) Parallel randomized trials of risk-based therapy for fetal alloimmune thrombocytopenia. Obstetrics and Gynecology, 107, 91-96.
9. Bertrand, G., Bianchi, F., Alexandre, M., Quesne, J., Chenet, C., Martageix, C., Jallu, V. & Kaplan, C. (2007) HPA-13bw neonatal alloimmune thrombocytopenia and low frequency alloantigens: case report and review of the literature. Transfusion, 47, 1510-1513.
10. Birchall, J.E., Murphy, M.F., Kaplan, C., Kroll, H.; European Fetomaternal Alloimmune Thrombocytopenia Study Group (2003) European collaborative study of the antenatal management of feto-maternal alloimmune thrombocytopenia. British Journal of Haematology, 122, 275-288.
11. Bussel, J. (2009) Diagnosis and management of the fetus and neonate with alloimmune thrombocytopenia. Journal of Thrombosis and Haemostasis, 17, 253-257.
12. Bussel, J.B., Berkowitz, R.L., Hung, C., Kolb, E.A., Wisser, M., Primiani, A., Tsaur, F.W. & Macfarland, J.G. (2010) Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetus. American Journal of Obstetrics and Gynecology, 203, 135.e1-135.e14.
13. Chakravorty, S. & Roberts, I. (2012) How I manage neonatal thrombocytopenia. British Journal of Haematology, 156, 155-162.
14. Chen, P., Li, C., Lang, S., Zhu, G., Reheman, A., Spring, C.M., Freedman, J. &Ni, H. (2010) Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy. Blood, 116, 3660-3668.
15. Chong, W., Metcalfe, P., Mushens, R., Lucas, G., Ouwehand, W.H. & Navarrete, C.V. (2011) Detection of human platelet antigen -1a alloantibodies in cases of fetomaternal alloimmune thrombocytopenia using recombinant β3 integrin fragments coupled to fluorescently labeled beads. Transfusion, 51, 1261-1270.
16. Curtis, B.R., Ali, S., Glazier, A.M., Ebert, D.D., Aitman, T.J. & Aster, R.H. (2002) Isoimmunization against CD36 (glycoprotein IV): description of four cases of neonatal isoimmune thrombocytopenia and brief review of the literature. Transfusion, 42, 1173-1179.
17. Dreyfus, M., Kaplan, C., Verdy, E., Schlegel, N., Durand-Zaleski, I. & Tchernia, G. (1997) Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood, 89, 4402-4406.
18. Ghevaert, C., Wilcox, D.A., Fang, J., Armour, K.L., Clark, M.R., Ouwehand, W.H. & Williamson, L.M. (2008) Developing recombinant HPA-1a-specific antibodies with abrogated Fcγ receptor binding for the treatment of fetomaternal alloimmune thrombocytopenia. The Journal of Clinical Investigation, 118, 2929-2938.
19. Ghevaert, C., Rankin, A., Huiskes, E., Porcelijn, L., Javela, K., Kekomaki, R., Bakchoul, T., Santoso, S., Nutland, S., Smyth, D.J., Smith, G.A., McBride, S., Watkins, N.A. & Ouwehand, W.H. (2009) Alloantibodies against low-frequency human platelet antigens do not account for a significant proportion of cases of fetomaternal alloimmune thrombocytopenia: evidence from 1054 cases. Transfusion, 49, 2084-2089.
20. Giers, G., Wenzel, F., Stockschläder, M., Riethmacher, R., Lorenz, H. & Tutschek, B. (2010) Fetal alloimmine thrombocytopenia and maternal intravenous immunoglobulin infusion. Haematologica, 95, 1921-1926.
21. van Gils, J.M., Stutterheim, J., van Duijn, T.J., Zwaginga, J.J., Porcelijn, L., de Haas, M. & Hordijk, P.L. (2009) HPA-1a alloantibodies reduce endothelial cell spreading and monolayer integrity. Molecular Immunology, 46, 406-415.
22. Hansen, R.J. & Balthasar, J.P. (2002) Intravenous immunoglobulin mediates an increase in anti-platelet antibody clearance via the FcRn receptor. Thrombosis and Haemostasis, 88, 898-899.
23. Hohlfeld, P., Forestier, F., Kaplan, C., Tissot, J.D. & Daffos, F. (1994) Fetal thrombocytopenia: a retrospective survey of 5194 fetal blood samplings. Blood, 84, 1851-1856.
24. Kamphuis, M.M. & Oepkes, D. (2011) Fetal and neonatal alloimmune thrombocytopenia: prenatal interventions. Prenatal Diagnosis, 31, 712-719.
25. Kamphuis, M.M., Paridaans, N., Porcelijn, L., De Haas, M., Van Der Schoot, C.E., Brand, A., Bonsel, G.J. & Oepkes, D. (2010) Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG: An International Journal of Obstetrics and Gynaecology, 117, 1335-1343.
26. Kankirawatana, S., Kupatawintu, P., Juji, T., Veerakul, G., Ngerncham, S., Chongkolwatana, V. & O'Charoen, R. (2001) Neonatal alloimmune thrombocytopenia due to anti-Nak(a). Transfusion, 41, 375-377.
27. Kaplan, C., Porelijin, L., Vanlieferinghen, P., Julien, E., Bianchi, F., Martageix, C., Bertrand, G. & Jallu, V. (2005) Anti-HPA9bw (MAXa) fetomaternal alloimmunization a clinically severe neonatal thrombocytopenia: difficulties in diagnosis and therapy and report on eight families. Transfusion, 45, 1799-1803.
28. Kiefel, V., Bassler, D., Kroll, H., Paes, B., Giers, G., Ditomasso, J., Alber, H., Berns, M., Wiebe, B., Quenzel, E.M., Hoch, J. & Greinacher, A. (2006) Antigen-positive platelet transfusion in neonatal alloimmune thrombocytopenia (NAIT). Blood, 107, 3761-3763.
29. Killie, M.K., Husebekk, A., Kjeldsen-Kragh, J. & Skogen, B. (2008) A prospective study of maternal anti-HPA1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn. Haematologica, 93, 870-877.
30. Kjeldsen-Kragh, J., Killie, M.K., Tomter, G., Golebiowska, E., Randen, I., Hauge, R., Aune, B., Øian, P., Dahl, L.B., Pirhonen, J., Lindeman, R., Husby, H., Haugen, G., Grønn, M., Skogen, B. & Husebekk, A. (2007) A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia. Blood, 110, 833-839.
31. Kjeldsen-Kragh, J., Ni, H. & Skogen, B. (2012) Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia. Current Opinion in Hematology, 19, 469-474.
32. Knight, M., Pierce, M., Allen, D., Kurinczuk, J.J., Spark, P., Roberts, D.J. & Murphy, M.F. (2011) The incidence and outcomes of fetomaternal alloimmune thrombocytopenia : a UK national study using three data sources. British Journal of Haematology, 152, 460-468.
33. Koh, Y., Ishii, H., Amakishi, E., Hayashi, T., Matsuyama, N., Fukumori, Y., Hirayama, F., Shimizu, J., Nakauchi, S. & Kawa, K. (2012) The first two cases of neonatal alloimmune thrombocytopenia associated with the low-frequency platelet antigen HPA-21bw (Nos) in Japan. Transfusion, 52, 1468-1475.
34. Kroll, H., Penke, G. & Santoso, S. (2005) Functional heterogeneity of alloantibdies against the human platelet antigen (HPA)-Ia. Thrombosis and Haemostasis, 94, 1224-1229.
35. Kumpel, B.M., Sibley, K., Jackson, D.J., White, G. & Soothill, P.W. (2008) Ultrastructural localization of glycoprotein IIIa (GPIIIa, β3 integrin) on placental syncytiotrophoblast microvilli: implications for platelet alloimmunization during pregnancy. Transfusion, 48, 2077-2086.
36. Landau, M. & Rosenberg, N. (2011) Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders. Transfusion, 51, 558-569.
37. Le Toriellec, E., Chenet, C. & Kaplan, C. (2011) Noninvasive fetal genotyping of human platelet antigen -1a. BJOG: An International Journal of Obstetrics and Gynaecology, 118, 1392-1395.
38. Le Toriellec, E., Chenet, C. & Kaplan, C. (2012) Safe fetal platelet genotyping: new developments. Transfusion, DOI: 10.1111/j.1537-2995.2012.03954.x.
39. Li, C., Li, J., Li, Y., Lang, S., Yougbare, I., Zhu, G., Chen, P. & Ni, H. (2012) Crosstalk between platelets and the immune system: old systems with new discoveries. Advances in Hematology, 2012, 1-14.
40. Loewenthal, R., Rosenberg, N., Kalt, R., Dardik, R., Landau, M., Yahalom, V., Avishai, O., Frenkel, O., Gazit, E., Steinberg, D.M., Lipitz, S. & Salomon, O. (2013) Compound heterozygosity of HLA-DRB3*01:01 and HLA-DRB4*01:01 as a potential predictor of fetal neonatal alloimmune thrombocytopenia. Transfusion, 53, 344-352.
41. Looney, C.B., Smith, J.K., Merck, L.H., Wolfe, H.M., Chescheir, N.C., Hamer, R.M. & Gilmore, J.H. (2007) Intracranial hemorrhage in asymptomatic neonates: prevalence on MRI images and relationship to obstetric and neonatal risk factors. Radiology, 242, 535-541.
42. Maślanka, K., Michur, H., Guz, K., Wróbel, A., Uhrynowska, M., Misiak, A., Eiduk, A., Brojer, E. & Zupańska, B. (2012) The relevance of HPA-15 antigen expression for anti-HPA15 antibody detection. International Journal of Laboratory Hematology, 34, 65-69.
43. Metcalfe, P., Watkins, N.A., Ouwehand, W.H., Kaplan, C., Newman, P., Kekomaki, R., De Haas, M., Aster, R., Shibata, Y., Smith, J., Kiefel, V. & Santoso, S. (2003) Nomencalture of human platelet antigens. Vox Sanguinis, 85, 240-245.
44. Newman, P.J., Derb, R.S. & Aster, R.H. (1989) The human platelet alloantigens, PlA1 and PlA2, are associated with a leucine33/proline33 amino acid polymorphism in membrane glycoprotein IIIa, and are distinguishable by DNA typing. The Journal of Clinical Investigation, 83, 1778-1781.
45. Pacheco, L.D., Berkowitz, R.L., Moise, K.J. Jr, Bussel, J.B., McFarland, J.G. & Saade, G.R. (2011) Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification. Obstetrics and Gynecology, 118, 1157-1163.
46. Paidas, M.J., Berkowitz, R.L., Lynch, L., Lockwood, C.J., Lapinski, R., McFarland, J.G. & Bussel, J.B. (1995) Alloimmune thrombocytopenia: fetal and neonatal losses related to cordocentesis. American Journal of Obsteric and Gynecology, 172, 475-479.
47. Peterson, J.A., Gitter, M.L., Kanack, A., Curtis, B., McFarland, J., Bougie, D. & Aster, R. (2010) New low-frequency platelet glycoprotein polymorphisms associated with neonatal alloimmune thrombocytopenia. Transfusion, 50, 324-333.
48. Peterson, J.A., Pechauer, S.M., Gitter, M.L., Kanack, A., Curtis, B.R., Reese, J., Kamath, V.M., McFarland, J.G. & Aster, R.H. (2012a) New platelet glycoprotein polymorphisms causing maternal immunization and neonatal alloimmune thrombocytopenia. Transfusion, 52, 1117-11124.
49. Peterson, J.A., Kanack, A., Nayak, D., Bougie, D.W., McFarland, J.G., Curtis, B.R. & Aster, R.H. (2012b) Prevalence and clinical significance of low-avidity HPA-1a antibodies in women exposed to HPA-1a during pregnancy. Transfusion, DOI: 10.1111/j.1537-2995.2012.03903.x.
50. Peterson, J.A., McFarland, J.G., Curtis, B.R. & Aster, R.H. (2013) Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. British Journal of Haematology, 161, 3-14.
51. Rink, B.D., Gonik, B., Chmait, R.H. & O'Shaughnessy, R. (2013) Maternal hemolysis after intravenous immunoglobulin treatment in fetal and neonatal alloimmune thrombocytopenia. Obstetrics and Gynecoogyl, 121, 471-473.
52. Rooks, V.J., Eaton, J.P., Ruess, L., Petermann, G.W., Keck-Wherley, J. & Pedersen, R.C. (2008) Prevalence and evolution of intracranial hemorrhage in asymptomatic term infants. American Journal of Neuroradiology, 29, 1082-1089.
53. Rousseau, J., Goldman, M. & David, M. (2004) HPA-5b (Bra) neonatal alloimmune thrombocytopenia in Quebec: incidence and clinical outcome in 31 cases. Transfusion, 44, 844-848.
54. a platelet alloantigen and affects receptor function. Thrombosis and Haemostasis, 107, 80-87.
55. Santoso, S., Amrhein, J., Hofmann, H.A., Sachs, U.J., Walka, M.M., Kroll, H. & Kiefel, V. (1999) A point mutation Thr(799)Met on the alpha(2) integrin ' of new human platelet alloantigen Sit(a) and affects collagen-induced aggregation. Blood, 84, 4103-4111.
56. Santoso, S., Kiefel, V., Richter, I.G., Sachs, U.J., Rahman, A., Carl, B. & Kroll, H. (2002) A functional platelet fibrinogen receptor with a deletion in the cystein- rich repeat region of the ß3 integrin : the Oe(a) alloantigen in the neonatal alloimmune thrombocytopenia. Blood, 99, 1205-1214.
57. Scheffer, P.G., Ait Soussan, A., Verhagen, O.J., Page-Christiaens, G.C., Oepkes, D., de Haas, M. & van der Schoot, C.E. (2011) Noninvasive fetal genotyping of human platelet antigen -1a. BJOG: An International Journal of Obstetrics and Gynaecology, 118, 1392-1395.
58. Socher, I., Andrei-Selmer, C., Bein, G., Kroll, H. & Santoso, S. (2009) Low-avidity HPA-1a alloantibodies in severe neonatal alloimmune thrombocytopenia are detectable with surface plasmon resonance technology. Transfusion, 49, 943-952.
59. Taketani, T., Ito, K., Mishima, S., Kanai, R., Uchiyama, A., Hirata, Y., Kumakura, S., Ishikura, H. & Yamaguchi, S. (2008) Neonatal isoimmune thrombocytopenia caused by type I CD36 deficiency having novel splicing isoforms of the CD36 gene. European Journal of Haematology, 81, 70-74.
60. Thibaut, J., Mérieux, Y., Rigal, D. & Gillet, G. (2012) A novel assay for the detection of anti-human platelet antigen antibodies (HPA-1a) based on peptide aptamer technology. Haematologica, 97, 696-704.
61. Tiller, H., Killie, M.K., Skogen, B., Øian, P. & Husebekk, A. (2009) Neonatal alloimmune thrombocytopenia in Norway: poor correlation rate with noscreening versus a general screening programme. BJOG: An International Journal of Obstetrics and Gynaecology, 116, 594-598.
62. Tiller, H., Killie, M.K., Chen, P., Eksteen, M., Husebekk, A., Skogen, B., Kjelsen-Kragh, J. & Ni, H. (2012) Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model. Transfusion, 52, 1446-1457.
63. Vinograd, C.A. & Bussel, J.B. (2010) Antenatal treatment of fetal alloimmune thrombocytopenia: a current prospective. Haematologica, 95, 1807-1811.
64. Yinon, Y., Spira, M., Salomon, O., Weiss, B., Chayen, B., Schiff, E. & Lipitz, S. (2006) Antenatal noninvasive treatment of patients at risk for alloimmune thrombocytopenia without a history of intracranial hemorrhage. American Journal of Obstetrics and Gynecology, 195, 1153-1157.